UCT-MSC Stem Cells for Spinal & Interventional Pain Practices
UCT-MSC Stem Cells for Spinal & Interventional Pain Practices
Stem Nova Network supplies 25M hUCT-MSC stem cells wholesale to licensed spinal surgery centers, interventional pain physicians, neurosurgeons, and spine-focused orthopedic practices. Credential verification is required prior to purchase.
Product
25M hUCT-MSC Vial — Research-Grade Biologic · Licensed Professional Use Only · Not FDA-Approved
Human umbilical cord tissue–derived mesenchymal stem cells sourced from first-pregnancy Wharton's Jelly donors. Supplied as a research-grade biologic for licensed professional use only. UCT-MSCs are the most extensively referenced cell type in the spinal and interventional pain biologic literature, with published studies examining a range of administration approaches.
- 25 Million live MSCs per vial — 97% post-thaw viability, lot-documented
- CD90: 100% · CD166: 100% — ISCT-defined MSC identity markers, flow cytometry confirmed
- Endotoxin: 0.935 EU/mL · Sterility: Negative · Mycoplasma: Negative at ≤ 0.02
- Full viral panel: HCV, HIV, HBV, HTLV, CMV, EBV, HHV, HPV, B19 — all Negative
- Sourced from an AATB-accredited, FDA-registered tissue establishment operating under cGTP standards (21 CFR Part 1271)
- Stored LN₂ vapor phase ≤ -140°C · Shipped on dry ice · Lot-specific CoA every order
Quality Documentation
Spinal and interventional pain applications require the highest documentation standard of any biologic use. Every Stem Nova Network UCT-MSC lot is independently tested and released with a lot-specific Certificate of Analysis covering:
| Parameter | Specification | SNN Lot Result |
|---|---|---|
| Post-Thaw Viability | ≥ 70% (industry standard) | 97% |
| Cell Count | ≥ 2.0 × 10⁷ cells/vial | 2.4 × 10⁷ cells/vial |
| CD90 Expression | ≥ 80% (ISCT standard) | 100% |
| CD166 Expression | ≥ 80% (ISCT standard) | 100% |
| Endotoxin | ≤ 10 EU/mL (USP <85>) | 0.935 EU/mL |
| Sterility | Negative (21 CFR 610.12) | Negative |
| Mycoplasma | Negative · ≤ 0.02 threshold | Confirmed ≤ 0.02 |
| Full Viral Panel (9 markers) | Negative | All Negative |
What to Require from a Biologic Supplier
Post-Thaw Viability ≥ 90% — Not Just ≥ 70%
Industry minimum is 70%. For applications where live cell delivery is the intent, viability at point of use matters significantly. Require lot-specific documentation — not a blanket product-line figure. SNN current lot: 97%.
Mycoplasma ≤ 0.02 — Lot-Specific
A stringent mycoplasma specification with lot-specific documentation is a key quality marker for any high-sensitivity application. Require the actual test result for the lot being shipped — not a general specification reference.
Full Nine-Marker Viral Screening Panel
HCV, HTLV, CMV, EBV, HIV, HBV, HHV, HPV, and B19 — all tested negative and documented on the lot-specific CoA. Non-negotiable for any allogeneic cell product.
Flow Cytometry — CD90 and CD166 ≥ 80%
ISCT-defined MSC identity markers confirmed by flow cytometry on the specific lot being shipped. Required documentation for any serious biologic supplier in this category.
AATB-Accredited, FDA-Registered Tissue Establishment
Sourcing from an AATB-accredited, FDA-registered facility operating under cGTP standards (21 CFR Part 1271) provides the strongest available manufacturing quality signal for allogeneic biologic products. These are facility credentials — not product approval.
Practice Types We Supply
Stem Nova Network supplies research-grade UCT-MSC biologics to licensed practitioners operating within their professional scope and applicable state medical board authority.
All practitioners must be licensed in their respective field. Treatment planning, patient selection, and all clinical decisions are individualized and entirely at the discretion of the licensed practitioner. These products have not been approved by the United States Food and Drug Administration.
Apply for Wholesale Access
Lot-specific CoAs, full viral panel documentation, mycoplasma-verified lots, and dedicated support — available to licensed spinal and interventional pain practitioners upon credential verification. Most practices approved within 24 hours.
Enroll Your Practice Today → Contact Our Team